Neoadjuvant Chemotherapy in Invasive Bladder Cancer

Partial table of contents:; STATE OF THE ART LECTURES; Chemotherapy for Invasive Bladder Tumors (H. Scher); The Role of Surgery in Initial Staging and Follow Up (H. Herr); Trial Design and Statistics (O. Dalesio); RANDOMIZED CLINICAL TRIALS; The Integration of Chemotherapy, Radiotherapy, and Transurethral Surgery in Bladder-Sparing Approaches for Patients with Invasive Tumors (W. Shipley, et al.); NON-RANDOMIZED CLINICAL TRIALS; Neoadjuvant Medium-Dose Methotrexate, Cisplatin in Category T3b-T4a (NOMO) Bladder Cancer (G. Pizzocaro, et al.); Neo-Adjuvant Intra-Arterial Chemotherapy in Locally Advanced Bladder Cancer (G. Chechile, et al.); Bladder Sparing Approach to Muscle Invasive Carcinoma of the Bladder (R. Marino & Z. Wajsman); ASSESSMENT OF RESPONSE; Evaluation of Tumor Response and Prognostic Factors in Patients with Bladder Cancer Undergoing Combined Radiotherapy and Chemotherapy (G. Jakse, et al.); Combination Chemotherapy Followed by Surgery: The Case for a Marker Lesion (L. Denis, et al.); Index.